mafosfamide has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almici, C; Caramatti, C; Carlo-Stella, C; Cottafavi, L; Dotti, GP; Mangoni, L; Rizzoli, V | 1 |
| Douay, L; Fouillard, L; Gorin, NC; Isnard, F; Laporte, JP; Lopez, M; Najman, A; Perot, C; Taillemite, JL; Van Den Akker, J | 1 |
2 other study(ies) available for mafosfamide and Chronic Illness
| Article | Year |
|---|---|
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
Topics: Adult; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Chronic Disease; Cyclophosphamide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Survival Rate; Transplantation, Autologous | 1994 |
[Bone marrow autograft treated with mafosfamide in the acceleration phase in chronic myeloid leukemia. Inversion of the clinical development].
Topics: Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Transplantation; Chronic Disease; Cyclophosphamide; Humans; In Vitro Techniques; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Transplantation, Autologous | 1989 |